Alexander Bloch

2.6k total citations
89 papers, 2.0k citations indexed

About

Alexander Bloch is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Alexander Bloch has authored 89 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 34 papers in Organic Chemistry and 19 papers in Oncology. Recurrent topics in Alexander Bloch's work include Biochemical and Molecular Research (26 papers), Synthesis and Characterization of Heterocyclic Compounds (13 papers) and Synthesis and Biological Evaluation (8 papers). Alexander Bloch is often cited by papers focused on Biochemical and Molecular Research (26 papers), Synthesis and Characterization of Heterocyclic Compounds (13 papers) and Synthesis and Biological Evaluation (8 papers). Alexander Bloch collaborates with scholars based in United States, Switzerland and Poland. Alexander Bloch's co-authors include Ruth W. Craig, Morris J. Robins, Ken Takeda, M. Bobek, Charles A. Nichol, Jun Minowada, James R. McCarthy, Ginger E. Dutschman, C. Coutsogeorgopoulos and Maire Hakala and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemistry.

In The Last Decade

Alexander Bloch

85 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Bloch United States 25 1.3k 507 310 245 201 89 2.0k
R W Brockman United States 32 1.7k 1.3× 376 0.7× 447 1.4× 453 1.8× 350 1.7× 70 2.7k
V. L. Narayanan United States 24 1.0k 0.8× 890 1.8× 406 1.3× 411 1.7× 160 0.8× 68 2.2k
G. A. LePage United States 29 1.7k 1.3× 324 0.6× 352 1.1× 300 1.2× 418 2.1× 106 2.4k
L. Lee Bennett United States 28 1.5k 1.2× 266 0.5× 494 1.6× 307 1.3× 419 2.1× 80 2.3k
Tai‐Shun Lin United States 24 1.1k 0.8× 455 0.9× 548 1.8× 213 0.9× 232 1.2× 51 2.0k
James H. Freisheim United States 29 1.8k 1.4× 559 1.1× 264 0.9× 260 1.1× 203 1.0× 124 2.8k
Y. Fulmer Shealy United States 27 1.2k 0.9× 900 1.8× 398 1.3× 186 0.8× 277 1.4× 119 2.0k
Thomas P. Zimmerman United States 26 1.1k 0.9× 135 0.3× 458 1.5× 277 1.1× 518 2.6× 68 2.1k
R. K. ROBINS United States 22 757 0.6× 343 0.7× 397 1.3× 142 0.6× 348 1.7× 73 1.5k
Maire Hakala United States 23 1.3k 1.0× 174 0.3× 128 0.4× 463 1.9× 113 0.6× 62 1.8k

Countries citing papers authored by Alexander Bloch

Since Specialization
Citations

This map shows the geographic impact of Alexander Bloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Bloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Bloch more than expected).

Fields of papers citing papers by Alexander Bloch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Bloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Bloch. The network helps show where Alexander Bloch may publish in the future.

Co-authorship network of co-authors of Alexander Bloch

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Bloch. A scholar is included among the top collaborators of Alexander Bloch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Bloch. Alexander Bloch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bloch, Alexander, et al.. (2014). Diurnal profiles of pedometer-determined physical activity in chronically ill and mobility-limited older adults: a cross-sectional study. BMC Public Health. 14(1). 1268–1268. 6 indexed citations
2.
Kingué, Samuel, et al.. (2010). Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon. EP Europace. 12(4). 482–487. 64 indexed citations
3.
Li, Zhanrong, et al.. (1997). Differential expression of proteins regulating cell cycle progression in growth vs. differentiation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1356(2). 149–159. 21 indexed citations
4.
Bloch, Alexander, et al.. (1995). Regulation of c-myb expression in ML-1 human myeloblastic leukemia cells by c-ets-1 protein. Advances in Enzyme Regulation. 35. 35–41. 8 indexed citations
5.
Zhao, Lishan, et al.. (1994). Differential effect of growth- and differentiation-inducing factors on the release of eicosanoids and phospholipids from ML-1 human myeloblastic leukemia cells. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1211(2). 161–170. 7 indexed citations
6.
Li, Zhanrong, et al.. (1994). Differential binding of nuclear c-ets-1 protein to an intron I fragment of the c-myb gene in growth versus differentiation.. PubMed. 5(11). 1243–51. 16 indexed citations
7.
Bloch, Alexander. (1993). Dynamics of interaction between DNA-specific antitumor agents and serum-contained cytokines in the initiation of ML-1 human myeloblastic leukemia cell differentiation.. PubMed. 7(8). 1219–24. 13 indexed citations
8.
Fujii, Yoshihiro, Tetsuo Takuma, & Alexander Bloch. (1990). A regulatory role for tumor necrosis factor (TNF) in ML-1 human myeloblastic leukemia cell maturation. Leukemia Research. 14(11-12). 941–947. 6 indexed citations
9.
Bloch, Alexander. (1989). Growth and differentiation signals as determinants of cancer cell proliferation. Advances in Enzyme Regulation. 28. 359–374. 6 indexed citations
11.
Bobek, M., Ying‐Chih Cheng, Enrico Mihich, & Alexander Bloch. (1980). Synthesis, Biologic Effects, and Biochemical Properties of Some 2’-Azido- and 2’-Amino-2’-Deoxyarabinofuranosyl Pyrimidines and Purines. Recent results in cancer research. 74. 78–83. 5 indexed citations
12.
Bloch, Alexander. (1975). Chemistry, biology, and clinical uses of nucleoside analogs. New York Academy of Sciences eBooks. 31 indexed citations
13.
Klein, Edmund, Gordon H. Burgess, Alexander Bloch, Halina Milgrom, & Ole A. Holtermann. (1975). THE EFFECTS OF NUCLEOSIDE ANALOGS ON CUTANEOUS NEOPLASMS*. Annals of the New York Academy of Sciences. 255(1). 216–224. 11 indexed citations
14.
Bobek, M., et al.. (1975). Preparation and biological activity of some aminoacyl and peptidyl derivatives of 2'-amino-2'-deoxyuridine. Journal of Medicinal Chemistry. 18(9). 955–957. 3 indexed citations
15.
Bloch, Alexander, et al.. (1975). Synthesis and biological activity of 5-fluoro-4'-thiouridine and some related nucleosides. Journal of Medicinal Chemistry. 18(8). 784–787. 55 indexed citations
16.
Bloch, Alexander. (1974). Cytidine 3′, 5′-monophosphate (cyclic CMP). Biochemical and Biophysical Research Communications. 58(3). 652–659. 55 indexed citations
17.
Kalman, Thomas I., et al.. (1973). Methylation of 4-thio-2′-deoxyuridylate by thymidylate synthetase. Biochemical and Biophysical Research Communications. 55(1). 210–217. 11 indexed citations
18.
Shuman, Dennis A., Alexander Bloch, Roland K. Robins, & Morris J. Robins. (1969). Synthesis and biological activity of certain 8-mercaptopurine and 6-mercaptopyrimidine S-nucleosides. Journal of Medicinal Chemistry. 12(4). 653–657. 10 indexed citations
19.
Bloch, Alexander, Morris J. Robins, & James R. McCarthy. (1967). The Role of the 5′-Hydroxyl Group of Adenosine in Determining Substrate Specificity for Adenosine Deaminase. Journal of Medicinal Chemistry. 10(5). 908–912. 90 indexed citations
20.
Fox, Jack J., Kyoichi A. Watanabe, & Alexander Bloch. (1966). Nucleoside Antibiotics. Progress in nucleic acid research and molecular biology. 5. 251–313. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026